Ascendis Pharma(NASDAQ:ASND) 
Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and Tran...
Website: http://www.ascendispharma.com
Founded: 2006
Full Time Employees: 330
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 145.34
H 147.49
L 139.64
C 142.67
V 576,851
10EMA 142.67
20EMA 142.67
60EMA 142.67
120EMA 142.67
250EMA 142.67